Literature DB >> 26291441

Fluorescence tagging and inducible depletion of PD-L2-expressing B-1 B cells in vivo.

Rebecca A Lee1, Changchuin Mao1, Hung Vo1, Wenda Gao2, Xuemei Zhong1.   

Abstract

L2pB1 cells are a subpopulation of B-1a B cells that express programmed death ligand 2 (PD-L2) as their unique cell surface marker. In mice, about 50% of peritoneal B-1a cells are L2pB1 cells. The remaining B-1a cells are L2nB1 (PD-L2(-) ) B-1a cells. L2pB1 cells differ from L2nB1 cells in their immunoglobulin repertoire, expression of interleukin 10, and their capacity to phagocytose phosphatidylcholine. The physiological roles of L2pB1 cells have not been investigated owing to the lack of an animal model that allows for specific depletion of L2pB1 cells. Here, we report a mouse model that enables specific tracking and inducible depletion of L2pB1 cells in vivo. Our data show that depletion of L2pB1 cells significantly reduces serum anti-phosphorylcholine (PC) IgM levels and IL-10 expression in the peritoneal cavity. This animal model provides a tool for the study of the immune regulatory functions of L2pB1 cells in health and disease.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  L2pB1 cells; TdTomato; ZsGreen; diphtheria toxin receptor; monoallelic expression

Mesh:

Substances:

Year:  2015        PMID: 26291441      PMCID: PMC4679664          DOI: 10.1111/nyas.12865

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  37 in total

1.  Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice.

Authors:  M Saito; T Iwawaki; C Taya; H Yonekawa; M Noda; Y Inui; E Mekada; Y Kimata; A Tsuru; K Kohno
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

2.  Primed peritoneal B lymphocytes are sufficient to transfer protection against Brugia pahangi infection in mice.

Authors:  Natalia Paciorkowski; Leonard D Shultz; T V Rajan
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Regulation of T cell activation and tolerance by PDL2.

Authors:  Yongliang Zhang; Yeonseok Chung; Caroline Bishop; Betsy Daugherty; Hilary Chute; Paige Holst; Carole Kurahara; Fred Lott; Ning Sun; Andrew A Welcher; Chen Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

4.  A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice.

Authors:  Xuemei Zhong; Stanley Lau; Chunyan Bai; Nicolas Degauque; Nichol E Holodick; Scott J Steven; Joseph Tumang; Wenda Gao; Thomas L Rothstein
Journal:  Arthritis Rheum       Date:  2009-12

5.  Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Indira Guleria; Arezou Khosroshahi; Tanuja Chitnis; Jaime Imitola; Miyuki Azuma; Hideo Yagita; Mohamed H Sayegh; Samia J Khoury
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

6.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Authors:  Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

7.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

8.  The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.

Authors:  Peter X Shaw; Carl S Goodyear; Mi-Kyung Chang; Joseph L Witztum; Gregg J Silverman
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

9.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

10.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline.

Authors:  T J Mercolino; A L Locke; A Afshari; D Sasser; W W Travis; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  6 in total

1.  Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4+ T Cell Polarization.

Authors:  Seung-Chul Choi; Zhiwei Xu; Wei Li; Hong Yang; Derry C Roopenian; Herbert C Morse; Laurence Morel
Journal:  J Immunol       Date:  2018-03-21       Impact factor: 5.422

Review 2.  B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus.

Authors:  Seung-Chul Choi; Laurence Morel
Journal:  Autoimmunity       Date:  2017-02       Impact factor: 2.815

3.  PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.

Authors:  Jerome T McKay; Marcela A Haro; Christina A Daly; Rama D Yammani; Bing Pang; W Edward Swords; Karen M Haas
Journal:  J Immunol       Date:  2017-08-02       Impact factor: 5.422

4.  An IgA mimicry of IgG that binds Polymeric Immunoglobulin Receptor for mucosa transcytosis.

Authors:  Changchuin Mao; Richard Near; Varuna Shibad; Xuemei Zhong; Wenda Gao
Journal:  Antib Ther       Date:  2020-07-25

5.  L2pB1 Cells Contribute to Tumor Growth Inhibition.

Authors:  Varuna Shibad; Ali Bootwala; Changchuin Mao; Hanna Bader; Hung Vo; Esther Landesman-Bollag; Conrad Guo; Angel Rubio; Richard Near; Wenda Gao; Sreekar Challa; Vennela Chukka; Jeffrey Gao; Avery Kelly; Tamar Landesman; Tyler VanHelene; Xuemei Zhong
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

6.  Lung-resident memory B cells protect against bacterial pneumonia.

Authors:  Kimberly A Barker; Neelou S Etesami; Anukul T Shenoy; Emad I Arafa; Carolina Lyon de Ana; Nicole Ms Smith; Ian Mc Martin; Wesley N Goltry; Alexander Ms Barron; Jeffrey L Browning; Hasmeena Kathuria; Anna C Belkina; Antoine Guillon; Xuemei Zhong; Nicholas A Crossland; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.